Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease

Stroke. 2009 Sep;40(9):e542. doi: 10.1161/STROKEAHA.109.553941. Epub 2009 Jul 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • Atorvastatin
  • Blood Pressure / drug effects
  • Brachial Artery / physiology
  • C-Reactive Protein / metabolism
  • Carotid Arteries / drug effects
  • Carotid Arteries / physiology
  • Cerebrovascular Circulation / physiology
  • Cerebrovascular Disorders / drug therapy*
  • Cerebrovascular Disorders / pathology
  • Databases, Factual
  • Double-Blind Method
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Female
  • Heptanoic Acids / administration & dosage
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Lipids / blood
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Pyrroles / administration & dosage
  • Pyrroles / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Stroke / drug therapy*
  • Stroke / pathology
  • Treatment Outcome
  • Vasodilation / physiology

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • Pyrroles
  • C-Reactive Protein
  • Atorvastatin